Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Atadja

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Nature Communications|October 17, 2015
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53Qi Fei, Ke Shang, Jianhua Zhang, et al.
Cancer Research|August 28, 2013
NSD2 is recruited through its PHD domain to oncogenic gene loci to drive multiple myelomaZheng Huang, Haiping Wu, Shannon Chuai, et al.
Plos One|January 11, 2017
Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EEDLing Li, Hailong Zhang, Man Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferationWei Qi, HoMan Chan, Lin Teng, et al.
Journal of Medicinal Chemistry|December 16, 2017
Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)H Ümit Kaniskan, Mohammad S Eram, Kehao Zhao, et al.
Journal of Medicinal Chemistry|January 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer EfficacyYing Huang, Jeff Zhang, Zhengtian Yu, et al.
Journal of Medicinal Chemistry|October 3, 2003
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)Stacy W Remiszewski, Lidia C Sambucetti, Kenneth W Bair, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2015
A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)H Ümit Kaniskan, Magdalena M Szewczyk, Zhengtian Yu, et al.
Nature Chemical Biology|January 31, 2017
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EEDWei Qi, Kehao Zhao, Justin Gu, et al.
Journal of Medicinal Chemistry|June 10, 2011
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitorsMichael D Shultz, Xueying Cao, Christine H Chen, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Nature Communications|October 17, 2015
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53Qi Fei, Ke Shang, Jianhua Zhang, et al.
Cancer Research|August 28, 2013
NSD2 is recruited through its PHD domain to oncogenic gene loci to drive multiple myelomaZheng Huang, Haiping Wu, Shannon Chuai, et al.
Plos One|January 11, 2017
Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EEDLing Li, Hailong Zhang, Man Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferationWei Qi, HoMan Chan, Lin Teng, et al.
Journal of Medicinal Chemistry|December 16, 2017
Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)H Ümit Kaniskan, Mohammad S Eram, Kehao Zhao, et al.
Journal of Medicinal Chemistry|January 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer EfficacyYing Huang, Jeff Zhang, Zhengtian Yu, et al.
Journal of Medicinal Chemistry|October 3, 2003
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)Stacy W Remiszewski, Lidia C Sambucetti, Kenneth W Bair, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2015
A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)H Ümit Kaniskan, Magdalena M Szewczyk, Zhengtian Yu, et al.
Nature Chemical Biology|January 31, 2017
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EEDWei Qi, Kehao Zhao, Justin Gu, et al.
Journal of Medicinal Chemistry|June 10, 2011
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitorsMichael D Shultz, Xueying Cao, Christine H Chen, et al.
Pageof 11